Black Bird Biotech, Inc. financial data

Symbol
BBBT on OTC
Industry
Miscellaneous Manufacturing Industries
Location
11961 Hilltop Road, Suite 22, Argyle, TX
State of incorporation
NV
Fiscal year end
December 31
Former names
Digital Development Partners, Inc. (to 6/21/2021), Cyprium Resources Inc. (to 8/12/2009)
Latest financial report
10-Q - Q3 2023 - Nov 20, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 11.2 % -83.5%
Quick Ratio 8.6 % -53.9%
Debt-to-equity -119 % +74.6%
Return On Equity 106 % -95.6%
Return On Assets -544 % +16.5%
Operating Margin -924 % +53.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 0 shares
Common Stock, Shares, Outstanding 1.79B shares +612%
Entity Public Float 3.26M USD -57%
Common Stock, Value, Issued 1.79M USD +612%
Weighted Average Number of Shares Outstanding, Basic 293M shares +49.5%
Weighted Average Number of Shares Outstanding, Diluted 1.92B shares +472%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 36.3K USD -61%
Cost of Revenue 23K USD -62%
Research and Development Expense 0 USD
General and Administrative Expense 277K USD -59.4%
Operating Income (Loss) -336K USD +81.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -899K USD -94%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -836K USD +63.7%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 66.2K USD -91.9%
Accounts Receivable, after Allowance for Credit Loss, Current 1.55K USD -60.3%
Inventory, Net 75.5K USD -16.3%
Other Assets, Current 44.4K USD -91.1%
Assets, Current 91.1K USD -43.1%
Operating Lease, Right-of-Use Asset 2.88K USD
Intangible Assets, Net (Excluding Goodwill) 190K USD
Other Assets, Noncurrent 1K USD
Assets 98.8K USD -41.4%
Liabilities, Current 1.02M USD +23.3%
Operating Lease, Liability, Noncurrent 2.88K USD
Liabilities 1.02M USD +23.6%
Retained Earnings (Accumulated Deficit) -4.88M USD -20.7%
Stockholders' Equity Attributable to Parent -923K USD -40.3%
Liabilities and Equity 98.8K USD -41.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -99K USD +75.1%
Net Cash Provided by (Used in) Financing Activities 61.8K USD +1549%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 2.5B shares +233%
Common Stock, Shares, Issued 1.79B shares +612%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.73K USD -91.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 10.2K USD
Operating Lease, Liability 4.33K USD
Depreciation 4.48K USD +2.31%
Operating Lease, Liability, Current 8.39K USD
Deferred Tax Assets, Operating Loss Carryforwards 1.15M USD +43.6%
Preferred Stock, Shares Issued 42K shares +47.4%
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 2.17M USD -30.8%
Preferred Stock, Shares Outstanding 42K shares +47.4%
Operating Leases, Future Minimum Payments, Due in Two Years 8.7K USD
Amortization of Intangible Assets 52.8K USD -50%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 4.35K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Operating Leases, Future Minimum Payments, Due in Three Years 725 USD
Operating Leases, Future Minimum Payments Due 13.8K USD
Interest Expense 522K USD +24.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%